PHR1296
Bifonazole
Pharmaceutical Secondary Standard; Certified Reference Material
Manufacturer: Supelco
CAS Number: 60628-96-8
Synonym(S): 1-(p,α-Diphenylbenzyl)imidazole
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 G | PHR1296-1-G | In Stock | ₹ 18,131.88 |
PHR1296 - 1 G
In Stock
Quantity
1
Base Price: ₹ 18,131.88
GST (18%): ₹ 3,263.738
Total Price: ₹ 21,395.618
grade
certified reference materialpharmaceutical secondary standard
Quality Level
300
Agency
traceable to Ph. Eur. B1110000
API family
bifonazole
CofA
current certificate can be downloaded
technique(s)
HPLC: suitablegas chromatography (GC): suitable
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
c1ccc(cc1)C(c2ccc(cc2)-c3ccccc3)n4ccnc4
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Medchemexpress LLC HY-B0301 500mg Medchemexpress, Bifonazole CAS:60628-96-8 Purity:>98% | -- | ₹ 3,157.16 | |
| | Bifonazole Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 19,507.68 | |
| | Sigma Aldrich Fine Chemicals Biosciences Bifonazole for system suitability European Pharmacopoeia (EP) Reference Standard | 60628-96-8 | MFCD00865567 | | -- | ₹ 23,896.91 | |
| | Sigma Aldrich Fine Chemicals Biosciences Bifonazole European Pharmacopoeia (EP) Reference Standard | 60628-96-8 | MFCD00865567 | | -- | ₹ 16,036.51 | |
| | Bifonazole | -- | ₹ 14,072.50 | |
| | 1H-Imidazole, 1-([1,1'-biphenyl]-4-ylphenylmethyl)- | -- | ₹ 513.36 - ₹ 17,026.44 | |
| | 60628-96-8 | Bifonazole | -- | ₹ 1,026.72 - ₹ 19,935.48 |
Related Products
Description
- General description: Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Bifonazole is a substituted imidazole analog with therapeutic potential in treating invasive mucosal infections. It exhibits antifungal activity by suppressing the proliferation of dermatophytes, yeasts and fungi affecting the skin and nails. Its mode of action involves blocking the fungal ergosterol biosynthetic pathway and additional inhibition of terpenoid biosynthesis.[1]
- Application: Bifonazole may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using spectrophotometric technique.[1][2]
- Biochem/physiol Actions: Bifonazole is an imidazole-based anti-fungal agent with broad spectrum activity against many fungi, molds, yeast and some Gram-positive bacteria. Bifonazole inhibits ergosterol biosynthetic protein 28 and Cytochrome P450 2B4.
- Analysis Note: These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.
- Other Notes: This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
- Footnote: To see an example of a Certificate of Analysis for this material enter LRAC3256 in the slot below. This is an example certificate only and may not be the lot that you receive.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Oral
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable